About Sathgen Therapeutics
Sathgen Therapeutics is a company based in Mumbai (India) founded in 2007. It operates as a B2B. The company has 1,482 employees as of March 31, 2023. Sathgen Therapeutics offers products and services including MSP008-22. Sathgen Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Mumbai, India
- Employees 1482 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Godavari Biorefineries Limited
- Date of Incorporation 12 Jan, 1956
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$243.25 M (USD)18.31as on Mar 31, 2023
-
Net Profit
$2.32 M (USD)-0.97as on Mar 31, 2023
-
EBITDA
$17.52 M (USD)9.28as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1482
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sathgen Therapeutics
Sathgen Therapeutics offers a comprehensive portfolio of products and services, including MSP008-22.
Treats advanced solid tumors and inhibits viral replication.
Funding Insights of Sathgen Therapeutics
Detailed funding history for Sathgen Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sathgen Therapeutics
Investment portfolio details for Sathgen Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sathgen Therapeutics
Detailed financials for Sathgen Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sathgen Therapeutics Comparisons
Peer comparison for Sathgen Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sathgen Therapeutics
Sathgen Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Sathgen Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sathgen Therapeutics
Complete news archive for Sathgen Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sathgen Therapeutics
Sathgen Therapeutics was founded in 2007.
Sathgen Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2023, the latest employee count at Sathgen Therapeutics is 1,482.
Annual revenue of Sathgen Therapeutics is $243.25M as on Mar 31, 2023.
Sathgen Therapeutics is a clinical-stage biotech company focused on discovering and developing innovative treatments for difficult-to-treat cancers and viral infections. They conduct clinical trials for their lead drug candidate, MSP008-22, to evaluate safety and efficacy. Backed by Godavari Biorefineries Limited, they use an integrated approach to target diseases as complex systems. Based in Mumbai, India, they collaborate with partners to improve patient quality of life.
Sathgen Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Sathgen Therapeutics offers MSP008-22.